Watch DRIO. Know when insiders buy.
One email the day a filing lands. Free.
DRIO
DarioHealth Corp.
3.68
−0.40 −9.80%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
76
PASS · shorts 76
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $36.1MP/E 0.6DIV YIELD —FCF YIELD -70.66%REV TTM —NET INCOME −$35.7MNET DEBT $33M52W 3.68 – 16.19SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$6.5M | −$7.9M | — | 0.85 | −$6.1M | $38K | −$6.1M | Aug 11 |
| Q1 2026 · Mar 31 | — | — | — | −$7.3M | −$8.2M | — | 1.25 | −$6M | $31K | −$6.1M | May 13 |
| Q4 2025 · Dec 31derived | — | — | — | −$8.6M | −$9M | — | 1.07 | −$5.9M | $26K | −$5.9M | Mar 19 |
| Q3 2025 · Sep 30 | — | — | — | −$9.5M | −$10.5M | — | 2.96 | −$7.3M | $41K | −$7.4M | Nov 13 |
| Q2 2025 · Jun 30 | — | — | — | −$9.2M | −$13M | — | 3.54 | −$6M | $44K | −$6.1M | Aug 11 |
| Q1 2025 · Mar 31 | — | — | — | −$9.4M | −$9.2M | — | 2.87 | −$6.7M | $31K | −$6.7M | May 13 |
| Q4 2024 · Dec 31derived | — | — | — | −$11.7M | −$9.6M | — | 1.89 | −$6.7M | $21K | −$6.8M | Mar 19 |
| Q3 2024 · Sep 30 | — | — | — | −$12M | −$12.3M | — | 4.91 | −$7.4M | $32K | −$7.4M | Nov 13 |
| Q2 2024 · Jun 30 | — | — | — | −$16.2M | −$13.6M | — | 0.08 | −$11.4M | $29K | −$11.4M | Aug 12 |
| Q1 2024 · Mar 31 | — | — | — | −$17.9M | −$7.2M | — | 0.20 | −$13.1M | $56K | −$13.2M | Aug 12 |
| Q4 2023 · Dec 31derived | — | — | — | −$14.2M | −$14.3M | — | 0.41 | −$7.3M | $83K | −$7.4M | Mar 10 |
| Q3 2023 · Sep 30 | — | — | — | −$15.5M | −$15.7M | — | 0.49 | −$8.6M | $281K | −$8.9M | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$36.7M | −$41.7M | — | 10.12 | −$25.9M | $142K | −$26.1M | — | — |
| FY2024 · to Dec 31 | — | — | −$57.7M | −$42.7M | — | 12.27 | −$38.6M | $138K | −$38.7M | — | — |
| FY2023 · to Dec 31 | — | — | −$56.2M | −$59.4M | — | 1.93 | −$30.4M | $584K | −$31M | — | — |
| FY2022 · to Dec 31 | — | — | −$56.8M | −$62.2M | — | 2.54 | −$47.8M | $442K | −$48.3M | $134K | — |
| FY2021 · to Dec 31 | — | — | −$76.5M | −$76.8M | — | 4.07 | −$50.4M | $261K | −$50.7M | — | — |
| FY2020 · to Dec 31 | — | — | −$29.9M | −$29.4M | — | 4.01 | −$17.7M | $118K | −$17.9M | — | — |
Every number comes from DarioHealth Corp.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.